Related references
Note: Only part of the references are listed.A Rare Mutation in SMAD9 Associated With High Bone Mass Identifies the SMAD-Dependent BMP Signaling Pathway as a Potential Anabolic Target for Osteoporosis
Celia L. Gregson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
A road map for understanding molecular and genetic determinants of osteoporosis
Tie-Lin Yang et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Biased GPCR signaling: Possible mechanisms and inherent limitations
Vsevolod V. Gurevich et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal Homeostasis
Berna Kaya et al.
CELL REPORTS (2020)
miR-26b modulates OA induced BMSC osteogenesis through regulating GSKβ/β-catenin pathway
He Hu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Kynurenic acid as the neglected ingredient of commercial baby formulas
Pawel Milart et al.
SCIENTIFIC REPORTS (2019)
Kruppel-like factor 3 inhibition by mutated lncRNA Reg1cp results in human high bone mass syndrome
Mi Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
The role of osteoblasts in energy homeostasis
Naomi Dirckx et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells
Xingyu Chai et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
LGR6 promotes osteogenesis by activating the Wnt/β-catenin signaling pathway
Sheng-Li Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
A role for G protein-coupled receptor 137b in bone remodeling in mouse and zebrafish
K. Urso et al.
BONE (2019)
Protective effect of lodoxamide on hepatic steatosis through GPR35
So-Yeon Nam et al.
CELLULAR SIGNALLING (2019)
The role of GPCRs in bone diseases and dysfunctions
Jian Luo et al.
BONE RESEARCH (2019)
Frizzleds as GPCRs - More Conventional Than We Thought!
Gunnar Schulte et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
Soo-Jin Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Sophoridine from Sophora Flower Attenuates Ovariectomy Induced Osteoporosis through the RANKL-ERK-NFAT Pathway
Xiaoying Zhao et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
The emerging pharmacology and function of GPR35 in the nervous system
Amanda E. Mackenzie et al.
NEUROPHARMACOLOGY (2017)
Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation
Francesco Resta et al.
NEUROPHARMACOLOGY (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis
Chuandong Wang et al.
CELL DEATH & DISEASE (2016)
GPR126 Protein Regulates Developmental and Pathological Angiogenesis through Modulation of VEGFR2 Receptor Signaling
Hengxiang Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Zaprinast and Rolipram Enhances Spatial and Emotional Memory in the Elevated Plus Maze and Passive Avoidance Tests and Diminishes Exploratory Activity in Naive Mice
Furuzan Akar et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2014)
Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long?
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Osteoporosis: now and the future
Tilman D. Rachner et al.
LANCET (2011)
GPR35 as a Novel Therapeutic Target
A. E. MacKenzie et al.
Frontiers in Endocrinology (2011)
Wnt/β-catenin signaling enhances osteoblastogenic differentiation from human periodontal ligament fibroblasts
Jung Sun Heo et al.
MOLECULES AND CELLS (2010)
Circulating Mesenchymal Stem Cells With Abnormal Osteogenic Differentiation in Patients With Osteoporosis
Luca Dalle Carbonare et al.
ARTHRITIS AND RHEUMATISM (2009)
Osteocytes, mechanosensing and Wnt signaling
Lynda F. Bonewald et al.
BONE (2008)
Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells
XD Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Share Paper
